Curated clinical source

Melanoma overview

A source-linked starting point for understanding melanoma, staging, treatment categories, and what to ask next.

Clinical source
Melanoma Treatment (PDQ) - Patient Version
Publisher
National Cancer Institute
Reuse posture
open-embed
Last checked
2026-05-20

Melanoma is a cancer that begins in melanocytes, the cells involved in skin pigment. The National Cancer Institute's PDQ patient summary is the primary source for this page.

What usually matters in the first conversations

Families are often trying to understand several layers at once:

  • where the melanoma started;
  • whether it has spread;
  • what the pathology report says;
  • whether mutation or genomic testing was done;
  • whether surgery, systemic therapy, radiation therapy, clinical trials, or supportive care should be discussed.

Treatment categories to discuss

NCI PDQ describes several treatment categories used in melanoma care. Which ones come up depends on stage, whether disease is removable, prior treatment, mutation results, age, health, and clinician judgment.

Use this page as a map for conversations, not as a treatment plan.

Questions to bring

  • What stage are we treating, and what information is still missing?
  • Do we need mutation testing, and has BRAF/NRAS/KIT/NF1/NTRK status been checked?
  • What is the goal of the next step: cure, control, symptom relief, or more information?
  • Should we get a melanoma specialty second opinion?
  • Are any clinical trials worth discussing now rather than later?